Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-10-26

FDA Approved: RUFINAMIDE — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved Aurobindo Pharma Limited's Rufinamide as a generic drug via an Original Application (ANDA 216549).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rufinamide (Rufinamide)

Snippet

ORIG AP for RUFINAMIDE (RUFINAMIDE)